Skip to main content
Entero Healthcare Solutions Limited logo

Entero Healthcare Solutions Limited — Investor Relations & Filings

Ticker · ENTERO ISIN · INE010601016 LEI · 335800JIMRC57GVQFT50 BSE.NS Wholesale and retail trade
Filings indexed 262 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country IN India
Listing BSE.NS ENTERO

About Entero Healthcare Solutions Limited

https://www.enterohealthcare.com/

Entero Healthcare Solutions Limited operates as a technology-driven healthcare supply chain platform. The company specializes in the distribution of pharmaceutical products, medical devices, surgical supplies, and over-the-counter goods. By leveraging a robust logistics infrastructure and proprietary technology, it connects manufacturers with a broad network of pharmacies, hospitals, and clinics. The platform focuses on streamlining the procurement process through data-driven inventory management and efficient fulfillment services. Its operations are characterized by a wide geographic reach and a commitment to improving the accessibility and availability of essential healthcare products. The company serves as a critical intermediary, providing value-added services such as real-time tracking and supply chain visibility to its partners.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 83% confidence The document is a compliance declaration by the company’s promoter under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations regarding encumbrances on shares for the fiscal year ended March 31, 2026. It is not an annual or interim report, audit report, earnings release, nor does it announce a management change or financial transaction. It is a regulatory submission to stock exchanges under SEBI rules. This fits the fallback category of Regulatory Filings (RNS).
2026-06-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is explicitly titled as the “Transcript of Earnings Call/Conference Call” for Q4 FY26 and contains the full text of the moderated earnings call including opening remarks, financial discussion, and Q&A with analysts. This matches the definition for a Call Transcript (Code: CT).
2026-06-02 English
Transcript of Earnings Call / Conference Call
Call Transcript Classification · 95% confidence The document is a full transcript of Entero Healthcare Solutions Limited’s Q4 FY26 earnings conference call, including a moderator introduction, management presentations, and a Q&A session. It was filed under SEBI Listing Regulations as a transcript of an earnings/conference call. This matches the ‘Call Transcript’ category.
2026-06-02 English
Clarification on Investor Queries relating to profit attributable to owners of the Company and minority interest for the Quarter ended 31st March 2026
Regulatory Filings Classification · 82% confidence The document is a formal stock exchange filing addressed to the Listing Compliance Departments of BSE and NSE, providing clarifications on investor queries regarding quarterly financial results. It does not contain the actual financial results or constitute an earnings release; it is simply an explanatory letter. This is a generic regulatory communication to the exchanges, thus a Regulatory Filing (RNS).
2026-05-28 English
Updates
Regulatory Filings Classification · 87% confidence The document is a letter addressed to listing compliance departments at BSE and NSE, providing clarifications on investor queries regarding quarterly financial results for the period ended March 31, 2026. It does not contain the actual financial statements or constitute a full interim report, nor does it announce the publication of a report. It is a regulatory communication to stock exchanges, falling into the miscellaneous filings category. Therefore, the correct classification is Regulatory Filings (RNS).
2026-05-28 English
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Regulatory Filings Classification · 85% confidence The document is an “Annual Secretarial Compliance Report” prepared by the Company Secretary and submitted under SEBI (Listing Obligations and Disclosure Requirements) Regulation 24A to the stock exchanges. It is not a financial report like a 10-K or interim report, nor an earnings release, capital update, or management change notice. Rather, it is a statutory compliance certificate/return filed with the regulators. Therefore it best fits the general “Regulatory Filings” category (Code: RNS) as a compliance document.
2026-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.